BENZENO SHARON — SEC Form 4 filings
SEC reporting owner CIK 1780854. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-30.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-06 to 2026-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 6 filings — 921,966 shares, $15,103,765 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
- Largest priced transaction: sale of 308,477 shares @ $16.91 ($5,216,346) in Adaptive Biotechnologies Corp, filed 2025-11-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | 7 | — | 10 legs · 921,966 sh · $15,103,765 | 37 |
Form 4 filings — BENZENO SHARON
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,034 @ $12.14 · Sale (S): 11,034 @ $21 · Option exercise (M): 1,837 @ $12.14 · Option exercise (M): 24,944 @ $8.46 · Option exercise (M): 24,944 @ $3.99 · Option exercise (M): 51,570 @ $8.12 · +6 more | EDGAR |
| 2026-03-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 63,103 @ $13.17 | EDGAR |
| 2026-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 39,063 @ $0 | EDGAR |
| 2025-12-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 4,290 @ $12.14 · Option exercise (M): 4,157 @ $8.46 · Option exercise (M): 4,157 @ $3.99 · Sale (S): 12,604 @ $16.85 · Option exercise (M): 4,290 (derivative) @ $0 · Option exercise (M): 4,157 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-24 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 133,032 @ $8.46 · Option exercise (M): 68,961 @ $12.14 · Sale (S): 297,925 @ $16.54 · Option exercise (M): 834 @ $6.27 · Option exercise (M): 20,834 @ $6.55 · Option exercise (M): 49,480 @ $6.55 · +12 more | EDGAR |
| 2025-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 109,973 @ $0 · Sale (S): 41,600 @ $6.98 · Sale (S): 3,065 @ $6.99 · Grant/award (A): 165,027 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 132,979 @ $0 · Sale (S): 10,746 @ $3.43 · Sale (S): 18,644 @ $3.44 · Grant/award (A): 199,549 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780854 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →